JONATHAN FLANAGAN to Polymorphism, Single Nucleotide
This is a "connection" page, showing publications JONATHAN FLANAGAN has written about Polymorphism, Single Nucleotide.
Connection Strength
0.542
-
Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood. 2013 Apr 18; 121(16):3237-45.
Score: 0.186
-
Identification of sequence variation in the galactose-1-phosphate uridyl transferase gene by dHPLC. Mol Genet Metab. 2004 Feb; 81(2):133-6.
Score: 0.099
-
Genetic variants in toll-like receptor 4 are associated with lack of steroid-responsiveness in pediatric ITP patients. Am J Hematol. 2020 04; 95(4):395-400.
Score: 0.075
-
The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil. Blood Cells Mol Dis. 2016 11; 62:32-37.
Score: 0.060
-
Genetic predictors for stroke in children with sickle cell anemia. Blood. 2011 Jun 16; 117(24):6681-4.
Score: 0.041
-
The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction. Hum Genet. 2006 Nov; 120(4):581-8.
Score: 0.030
-
Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia. Blood Adv. 2024 11 12; 8(21):5529-5538.
Score: 0.026
-
Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia. PLoS One. 2016; 11(10):e0164364.
Score: 0.015
-
Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia. Blood. 2011 Nov 03; 118(18):4985-91.
Score: 0.010